BSEInsider Trading / SAST27 Sept 2026 · 27 Sept 2026, 09:36 pm

We hereby inform you that the Trading Window for dealing in the securities of the company shall remain closed for all designated persons and their Immediate Relatives with effected from October 01, 2026.

Asarfi Hospital Ltd · 543943

✦ AI Summaryinsider

Asarfi Hospital Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Asarfi Hospital Ltd - 543943 - Closure of Trading Window

Attachments (1)

📄

780f1ba2-5406-446f-b102-4cf2a3b14a9f.pdf

pdf

Download →
View document text
असफ(cid:334) हॉ(cid:729)ीटल सबके िलए (cid:738)ा(cid:726) Ref. No.: AHL/AO/2026/1403 Date: 26.09.2026 The BSE Limited Listing Department 25th Floor, Phiroze Jeejeebhoy Tower Dalal Street, Mumbai – 400001 Subject: Intimation regarding Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 Ref.: Scrip Code: 543943 Dear Sir/Madam, Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and the Company's Code of Conduct for Prevention of Insider Trading, we hereby inform you that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons and their Immediate Relatives with effect from October 01, 2026. The Trading Window shall remain closed until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter & half year ended September 30, 2026. The date of the Board Meeting for consideration and approval of the Unaudited Financial Results for the quarter & half year ended September 30, 2026, shall be intimated separately in due course. You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For Asarfi Hospital Limited CS Sudipa Singh Company Secretary & Compliance Officer Asarfi Hospital Limited Baramuri, P.O.: B Polytechnic, Dhanbad 828 130 || CIN: L85110JH2005PLC011673 Branch Office: Khatal Road, Dhaiya, ISM, Dhanbad 826004 || www.asarfihospital.com Phone: 7808368888, 9234302735 || Email: info@asarfihospital.com